Should your research become a company?

Should your research become a company?

Close-up of precise pipetting into labelled test tubes

Most innovations don’t fail because of science. They fail because the path to translation is unclear.

  • Many researchers try to build a company too early
  • Many look for funding before defining the product
  • Many struggle to find a CEO for something that is not company-ready

A simple path from idea to execution

DRG Innovation
DRG Innovation

Base Camp

Free tools and reality check

DRG Innovation
DRG Innovation

AIMS

Deep translation readiness analysis

DRG Innovation
DRG Innovation

Execution

Funding, team, validation, and next steps

A quick diagnostic to determine whether your idea is ready for commercialization—or not yet.

AIMS — Translation Readiness Review

A structured system to assess your idea, define the product, estimate costs, build a business case, and connect with the right partners.

  • Product clarity
  • Market and pricing
  • Cost and investment
  • Roadmap
  • Connections (investors, CROs, and other resources)
Droplet being dispensed into a laboratory sample vial
Scientist in protective gear examining samples through a microscope

Who This Is For

  • Academic researchers
  • Clinicians with product ideas
  • Early-stage medtech and digital health innovators
Display of organised vaping devices in a laboratory test setup

Not sure where your project stands? Start with the tool or request a conversation.

© 2025 DRG Innovation